The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life

N/AEnrolling By InvitationNCT05195515

Aarhus University Hospital2,000 enrolled

Overview

Bladder Cancer prognosis, treatment, and subsequent morbidity and mortality vary between the different stages, thus resulting in a different impact on patients' lives. There are some well known late effects of the treatments for bladder cancer, but the knowledge of their impact on patients Quality of Life is sparse. This study aims to determine the prevalence of late effects impact on Quality of Life and potential risk factors for impairment.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Bladder Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients are eligible if they are referred to a hospital in the Central Region Denmark, due to hematuria between 01/01/2022 and 01/01/2023 * Ability to understand written and oral Danish Exclusion Criteria: * Known Alzheimers disease * Diagnosed other causes explaining the hematuria

Locations (5)

Department of Urology, Aarhus University Hospital

Aarhus N, Denmark

Department of Urology, Regional Hospital Gødstrup

Gødstrup, Denmark

Department of Urology, Regional Hospital Horsens

Horsens, Denmark

Department of Urology, Regional Hospital Randers

Randers, Denmark

Outcomes

Primary Outcomes

Health-related Quality of Life

Changes in Quality of Life measured using validated instruments

Time frame: 5 years from baseline inclusion

Secondary Outcomes

Prevalence of late effects

Based on Patient Reported Outcomes and medical records

Time frame: 5 years from baseline inclusion

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.